EGFR and AIDS dementia complex: Furthermore, the EGFR tyrosine kinase inhibitor (EGFR-TKI), osimertinib, dacomitinib, afatinib, gefitinib and erlotinib, have shown superior clinical survival benefits in lung SCC and/or ADC patients with EGFR mutation [24,25,26,27].